Prevalence and risk factors of acne scars in patients with acne vulgaris
Background Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne. Materials and methods A systematic search of published studies in thr...
Saved in:
| Published in: | Skin research and technology Vol. 29; no. 6; pp. e13386 - n/a |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
John Wiley & Sons, Inc
01.06.2023
|
| Subjects: | |
| ISSN: | 0909-752X, 1600-0846, 1600-0846 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne.
Materials and methods
A systematic search of published studies in three databases was performed and the meta‐analyses were conducted.
Results
Finally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38–56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19–2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26–5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54–3.57; OR for severe acne: 5.51, 95% CI: 2.45–12.41).
Conclusion
Herein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important. |
|---|---|
| AbstractList | Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne.BACKGROUNDAcne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne.A systematic search of published studies in three databases was performed and the meta-analyses were conducted.MATERIALS AND METHODSA systematic search of published studies in three databases was performed and the meta-analyses were conducted.Finally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38-56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19-2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26-5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54-3.57; OR for severe acne: 5.51, 95% CI: 2.45-12.41).RESULTSFinally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38-56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19-2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26-5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54-3.57; OR for severe acne: 5.51, 95% CI: 2.45-12.41).Herein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important.CONCLUSIONHerein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important. Background Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne. Materials and methods A systematic search of published studies in three databases was performed and the meta‐analyses were conducted. Results Finally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38–56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19–2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26–5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54–3.57; OR for severe acne: 5.51, 95% CI: 2.45–12.41). Conclusion Herein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important. Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne. A systematic search of published studies in three databases was performed and the meta-analyses were conducted. Finally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38-56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19-2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26-5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54-3.57; OR for severe acne: 5.51, 95% CI: 2.45-12.41). Herein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important. Background Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global prevalence and risk factors of acne scars in patients with acne. Materials and methods A systematic search of published studies in three databases was performed and the meta‐analyses were conducted. Results Finally, we included 37 studies involving 24 649 acne patients. And, the pooled prevalence of acne scars in these patients was 47% (95% confidence interval [CI]: 38–56%). Besides, the differences in prevalence were observed based on the subgroup analysis for age, gender, acne severity, source of patients, and so on. Subsequently, we quantified the relationship of three risk factors with acne scars: male gender (odds ratio [OR]: 1.58, 95% CI: 1.19–2.09), positive family history of acne (OR: 2.73, 95% CI: 1.26–5.91), and acne severity (OR for moderate acne: 2.34, 95% CI: 1.54–3.57; OR for severe acne: 5.51, 95% CI: 2.45–12.41). Conclusion Herein, we found that 47% of acne patients suffered from acne scars and identified three risk factors: male gender, positive family history of acne, and acne severity. In order to reduce acne scarring, attention and effective therapy early in the course of acne is important. |
| Author | Chen, Tingqiao Zhong, Judan Chen, Jin Shao, Xinyi Chen, Yangmei Xue, Yuzhou Liu, Lin |
| Author_xml | – sequence: 1 givenname: Lin surname: Liu fullname: Liu, Lin organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 2 givenname: Yuzhou surname: Xue fullname: Xue, Yuzhou organization: Peking University Third Hospital – sequence: 3 givenname: Yangmei surname: Chen fullname: Chen, Yangmei organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 4 givenname: Tingqiao surname: Chen fullname: Chen, Tingqiao organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 5 givenname: Judan surname: Zhong fullname: Zhong, Judan organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 6 givenname: Xinyi surname: Shao fullname: Shao, Xinyi organization: The First Affiliated Hospital of Chongqing Medical University – sequence: 7 givenname: Jin surname: Chen fullname: Chen, Jin email: chenjin19771010@163.com organization: The First Affiliated Hospital of Chongqing Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37357642$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1LAzEQhoMotlYP_gFZ8KKH1Xxskt2jFLVCQfEDvIXZbFaj22xNdlv898a2XkTnMgzzvC_DvHto27XOIHRI8BmJdR58d0YYy8UWGhKBcYrzTGyjIS5wkUpOnwdoL4Q3jDEvCNtFAyYZlyKjQzS582YBjXHaJOCqxNvwntSgu9aHpK0T0M4kQUOcrEvm0FnjupAsbfe63i365gWiah_t1NAEc7DpI_R0dfk4nqTT2-ub8cU01SzPRZoxKVlZGc6IrEBKQ6gQklclrQURNTMgC0lKVoDgBMpM0CqrOdXAS1ExoGyETta-c99-9CZ0amaDNk0DzrR9UDSnhcRcZEVEj3-hb23vXbxuRTGR0xV1tKH6cmYqNfd2Bv5T_fwoAudrQPs2BG9qpW0XH9G6zoNtFMHqOwUVU1CrFKLi9Jfix_QvduO-tI35_B9UD_ePa8UXdaqU1w |
| CitedBy_id | crossref_primary_10_1080_02652048_2024_2326085 crossref_primary_10_7759_cureus_57200 crossref_primary_10_7759_cureus_65800 crossref_primary_10_1111_srt_13766 crossref_primary_10_1111_srt_13545 crossref_primary_10_1111_jocd_16695 crossref_primary_10_1007_s10103_024_04192_y crossref_primary_10_1007_s00238_024_02262_6 crossref_primary_10_3390_jaestheticmed1010002 crossref_primary_10_1007_s40124_025_00344_y crossref_primary_10_1016_j_jmst_2024_12_099 crossref_primary_10_1097_JD9_0000000000000394 crossref_primary_10_3390_antibiotics14080844 crossref_primary_10_3390_life15081196 crossref_primary_10_1111_srt_13573 crossref_primary_10_2147_CCID_S504281 crossref_primary_10_1111_jocd_70183 crossref_primary_10_1111_ahg_70014 crossref_primary_10_1111_jocd_70266 crossref_primary_10_1111_jocd_16663 crossref_primary_10_1007_s13555_025_01344_y crossref_primary_10_32902_2663_0338_2025_1_38_42 crossref_primary_10_1111_srt_13541 crossref_primary_10_1155_dth_4228323 crossref_primary_10_1007_s12634_025_3030_0 |
| Cites_doi | 10.1111/bjd.17721 10.1111/bjd.16481 10.1684/ejd.2015.2713 10.1111/bjd.13462 10.1111/srt.12657 10.1007/s40257-014-0072-x 10.1016/j.clindermatol.2016.10.004 10.1111/jdv.14325 10.1046/j.1365-2133.1997.d01-1144.x 10.1016/0190-9622(92)70135-3 10.1111/j.1600-0625.2007.00654.x 10.1007/s40257-021-00628-1 10.1038/jid.2013.446 10.1111/j.1468-3083.2011.04330.x 10.1038/nrdp.2015.29 10.1111/bjd.17851 10.1016/j.jaad.2008.05.029 10.1111/j.1365-2133.2009.09258.x 10.1111/1346-8138.12885 10.1111/bjd.16680 10.1002/lsm.23008 10.1111/jdv.15419 10.1111/jocd.14040 10.1111/j.1365-2133.2004.05749.x |
| ContentType | Journal Article |
| Copyright | 2023 The Authors. published by John Wiley & Sons Ltd. 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. 2023. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2023 The Authors. published by John Wiley & Sons Ltd. – notice: 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. – notice: 2023. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 |
| DOI | 10.1111/srt.13386 |
| DatabaseName | Wiley-Blackwell Open Access Titles CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Engineering |
| EISSN | 1600-0846 |
| EndPage | n/a |
| ExternalDocumentID | 37357642 10_1111_srt_13386 SRT13386 |
| Genre | article Systematic Review Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: n82073462 – fundername: National Natural Science Foundation of China grantid: n82073462 |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABUWG ACAHQ ACBWZ ACCFJ ACCMX ACGFS ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXQS ACYXJ ADBBV ADEOM ADIYS ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFRAH AFZJQ AHEFC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 CAG CCPQU COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 FEDTE FUBAC FYUFA FZ0 G-S G.N GODZA H.X HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY AIQQE CITATION O8X PHGZM CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 |
| ID | FETCH-LOGICAL-c3886-43773bde5317da77e126675db2f616f3ea7971b39a651ab462d4f52ca5b6d3a23 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 27 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000999066800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0909-752X 1600-0846 |
| IngestDate | Sun Sep 28 06:59:23 EDT 2025 Sat Nov 29 14:53:07 EST 2025 Wed Feb 19 02:05:53 EST 2025 Sat Nov 29 07:54:32 EST 2025 Tue Nov 18 22:18:54 EST 2025 Wed Jan 22 16:22:07 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | acne vulgaris prevalence acne scar acne risk factor |
| Language | English |
| License | Attribution 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3886-43773bde5317da77e126675db2f616f3ea7971b39a651ab462d4f52ca5b6d3a23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fsrt.13386 |
| PMID | 37357642 |
| PQID | 2829368249 |
| PQPubID | 1106343 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2829705649 proquest_journals_2829368249 pubmed_primary_37357642 crossref_citationtrail_10_1111_srt_13386 crossref_primary_10_1111_srt_13386 wiley_primary_10_1111_srt_13386_SRT13386 |
| PublicationCentury | 2000 |
| PublicationDate | June 2023 2023-06-00 2023-Jun 20230601 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: June 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Copenhagen |
| PublicationTitle | Skin research and technology |
| PublicationTitleAlternate | Skin Res Technol |
| PublicationYear | 2023 |
| Publisher | John Wiley & Sons, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc |
| References | 2015; 1 1997; 136 2017; 31 2015; 172 2019; 181 2021; 20 2019; 51 2013; 27 2019; 33 2017; 16 2015; 42 2018; 179 2004; 150 2017; 35 2019; 25 2008; 17 2022; 23 2008; 59 2014; 15 2009; 161 1992; 26 2016; 26 2014; 134 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_22_1 Tan J (e_1_2_9_20_1) 2017; 16 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 Tan J (e_1_2_9_12_1) 2017; 16 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_27_1 |
| References_xml | – volume: 26 start-page: 931 year: 1992 end-page: 935 article-title: The prevalence of acne on the basis of physical examination publication-title: J Am Acad Dermatol – volume: 16 start-page: 97 year: 2017 end-page: 102 article-title: Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA publication-title: Journal of drugs in dermatology : JDD – volume: 27 start-page: 643 year: 2013 end-page: 646 article-title: Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities publication-title: Journal of the European Academy of Dermatology and Venereology : JEADV – volume: 181 start-page: 1226 year: 2019 end-page: 1237 article-title: Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor‐β1 signalling publication-title: The British journal of dermatology – volume: 51 start-page: 104 year: 2019 end-page: 113 article-title: Acne vulgaris severity graded by in vivo reflectance confocal microscopy and optical coherence tomography publication-title: Lasers Surg Med – volume: 179 start-page: 906 year: 2018 end-page: 917 article-title: Atrophic scar formation in patients with acne involves long‐acting immune responses with plasma cells and alteration of sebaceous glands publication-title: Br J Dermatol – volume: 25 start-page: 347 year: 2019 end-page: 354 article-title: Gender‐ and age‐related differences in facial sebaceous glands in Asian skin, as observed by non‐invasive analysis using three‐dimensional ultrasound microscopy publication-title: Skin Res Technol – volume: 136 start-page: 66 year: 1997 end-page: 70 article-title: Post‐adolescent acne: a review of clinical features publication-title: Br J Dermatol – volume: 150 start-page: 72 year: 2004 end-page: 81 article-title: Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar publication-title: Br J Dermatol – volume: 31 start-page: 1547 year: 2017 end-page: 1554 article-title: Development of an atrophic acne scar risk assessment tool publication-title: Journal of the European Academy of Dermatology and Venereology : JEADV – volume: 172 start-page: 3 issue: 1 year: 2015 end-page: 12 article-title: A global perspective on the epidemiology of acne publication-title: Br J Dermatol – volume: 181 start-page: 665 year: 2019 end-page: 676 article-title: What does acne genetics teach us about disease pathogenesis? publication-title: Br J Dermatol – volume: 35 start-page: 130 year: 2017 end-page: 137 article-title: Sex hormones and acne publication-title: Clin Dermatol – volume: 15 start-page: 307 year: 2014 end-page: 321 article-title: Follicular and scarring disorders in skin of color: presentation and management publication-title: Am J Clin Dermatol – volume: 42 start-page: 690 year: 2015 end-page: 696 article-title: Prevalence of scars and “mini‐scars”, and their impact on quality of life in Japanese patients with acne publication-title: J Dermatol – volume: 26 start-page: 68 year: 2016 end-page: 74 article-title: Different cutaneous innate immunity profiles in acne patients with and without atrophic scars publication-title: Eur J Dermatol – volume: 161 start-page: 8 year: 2009 end-page: 18 article-title: Genetic susceptibility to raised dermal scarring publication-title: Br J Dermatol – volume: 59 start-page: 659 year: 2008 end-page: 676 article-title: Acne scarring: a review and current treatment modalities publication-title: J Am Acad Dermatol – volume: 16 start-page: 97 year: 2017 end-page: 102 article-title: Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA publication-title: J Drugs Dermatol – volume: 23 start-page: 115 year: 2022 end-page: 123 article-title: Impact of facial atrophic acne scars on quality of life: a multi‐country population‐based survey publication-title: American journal of clinical dermatology – volume: 17 start-page: 610 year: 2008 end-page: 613 article-title: Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro‐Caribbeans publication-title: Exp Dermatol – volume: 179 start-page: 282 year: 2018 end-page: 289 article-title: Incidence and prevalence of rosacea: a systematic review and meta‐analysis publication-title: Br J Dermatol – volume: 20 start-page: 3672 year: 2021 end-page: 3678 article-title: Prevalence of acne vulgaris and its clinico‐epidemiological pattern in adult patients: results of a prospective, observational study publication-title: Journal of cosmetic dermatology – volume: 1 year: 2015 article-title: Acne vulgaris publication-title: Nat Rev Dis Primers – volume: 33 start-page: 937 year: 2019 end-page: 943 article-title: Acne relapses: impact on quality of life and productivity publication-title: J Eur Acad Dermatol Venereol – volume: 134 start-page: 1527 year: 2014 end-page: 1534 article-title: The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions publication-title: J Invest Dermatol – ident: e_1_2_9_14_1 doi: 10.1111/bjd.17721 – ident: e_1_2_9_11_1 doi: 10.1111/bjd.16481 – ident: e_1_2_9_15_1 doi: 10.1684/ejd.2015.2713 – ident: e_1_2_9_21_1 doi: 10.1111/bjd.13462 – ident: e_1_2_9_23_1 doi: 10.1111/srt.12657 – ident: e_1_2_9_25_1 doi: 10.1007/s40257-014-0072-x – ident: e_1_2_9_22_1 doi: 10.1016/j.clindermatol.2016.10.004 – ident: e_1_2_9_10_1 doi: 10.1111/jdv.14325 – ident: e_1_2_9_24_1 doi: 10.1046/j.1365-2133.1997.d01-1144.x – ident: e_1_2_9_9_1 doi: 10.1016/0190-9622(92)70135-3 – ident: e_1_2_9_26_1 doi: 10.1111/j.1600-0625.2007.00654.x – ident: e_1_2_9_3_1 doi: 10.1007/s40257-021-00628-1 – volume: 16 start-page: 97 year: 2017 ident: e_1_2_9_12_1 article-title: Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA publication-title: Journal of drugs in dermatology : JDD – ident: e_1_2_9_2_1 doi: 10.1038/jid.2013.446 – ident: e_1_2_9_5_1 doi: 10.1111/j.1468-3083.2011.04330.x – ident: e_1_2_9_18_1 doi: 10.1038/nrdp.2015.29 – ident: e_1_2_9_4_1 doi: 10.1111/bjd.17851 – ident: e_1_2_9_6_1 doi: 10.1016/j.jaad.2008.05.029 – volume: 16 start-page: 97 year: 2017 ident: e_1_2_9_20_1 article-title: Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA publication-title: J Drugs Dermatol – ident: e_1_2_9_27_1 doi: 10.1111/j.1365-2133.2009.09258.x – ident: e_1_2_9_8_1 doi: 10.1111/1346-8138.12885 – ident: e_1_2_9_17_1 doi: 10.1111/bjd.16680 – ident: e_1_2_9_19_1 doi: 10.1002/lsm.23008 – ident: e_1_2_9_7_1 doi: 10.1111/jdv.15419 – ident: e_1_2_9_13_1 doi: 10.1111/jocd.14040 – ident: e_1_2_9_16_1 doi: 10.1111/j.1365-2133.2004.05749.x |
| SSID | ssj0005913 |
| Score | 2.46384 |
| SecondaryResourceType | review_article |
| Snippet | Background
Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the... Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the global... Background Acne scar is a persistent complication of acne vulgaris. However, the prevalence and risk factors are still unclear. This study aimed to assess the... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e13386 |
| SubjectTerms | Acne acne scar acne vulgaris Acne Vulgaris - complications Acne Vulgaris - epidemiology Cicatrix - epidemiology Cicatrix - pathology Gender Genetics Humans Male Males Prevalence risk factor Risk Factors Scars Subgroups Treatment Outcome |
| Title | Prevalence and risk factors of acne scars in patients with acne vulgaris |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fsrt.13386 https://www.ncbi.nlm.nih.gov/pubmed/37357642 https://www.proquest.com/docview/2829368249 https://www.proquest.com/docview/2829705649 |
| Volume | 29 |
| WOSCitedRecordID | wos000999066800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1600-0846 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005913 issn: 0909-752X databaseCode: 7X7 dateStart: 20220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1600-0846 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005913 issn: 0909-752X databaseCode: BENPR dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1600-0846 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005913 issn: 0909-752X databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1600-0846 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005913 issn: 0909-752X databaseCode: 24P dateStart: 20220101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oFNEH75fpHFF88KVimluLT142fNAx5oW9lTRNYSCdrJu_36Tp6oYKgi9pIac0JDnJOTkn3wdwlhBNOdfMM9OFesb_wl7AWegZY8JYu5QoFy54fRCdTtDvh90FuJrehXH4ENWBm9WMYr22Ci7jfEbJ89H4wjpYfBGWMCaB5W3wafcrvyN03MjhZegJ5vdLWCGbxlN9Or8ZfbMw5w3WYsdpb_yrrZuwXhqa6NrNjC1Y0Nk2rM3AD27DymMZWN-BewvlJIsLSEhmCbIZ56jk4kHDFEmVaZQr4wWjQYZKMNYc2VNcV_cxsXdCBvkuvLRbz7f3Xkmy4CkSBNyjRAgSJ9rookikEBqbLVuwJPZTjnlKtBShwDEJJWdYxpT7CU2ZrySLeUKkT_aglg0zfQBIUWXWPxanKkgos2w2IlVS-FoxrC5jXIfzaW9HqkQgt0QYb9HUEzH9FBX9VIfTSvTdwW78JNSYDllUal4e2cgw4YHxKutwUlUbnbGBEJnp4cTJCGP5WZl9N9TVX4ggxgWjvmlsMaK__z566j0XL4d_Fz2CVctX73LNGlAbjyb6GJbVx3iQj5rFBDal6IuiDJqwdNPqdHvmeddrvzx8Avzm9TI |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED90ih8Pfn9Mp0bxwZeKbb5a8EVEmTjH0Cl7K2mSwkA6WTf_fpOmqxMVBN8KuZKQu8vd5S6_AzhVWBPGNPWMuBDPxF--FzIaecaZMN4uwdKlC15avN0Oe72oMwOXk7cwDh-iunCzmlGc11bB7YX0lJbnw9G5jbDYLMwRY2WslAek81ngEbnmyNFF5HEa9EpcIVvHU_361Rp9czG_eqyFybld_d9i12CldDXRlZONdZjR2QYsTwEQbsDCQ5la34SmBXMSxRMkJDKFbM05KrvxoEGKhMw0yqWJg1E_QyUca47sPa4bex_bVyH9fAueb2-6102vbLPgSRyGzCOYc5wobbSRK8G59o3R5lQlQcp8lmIteMT9BEeCUV8khAWKpDSQgiZMYRHgbahlg0zvApJEmhOQJqkMFaG2nw1PpeCBltSXF4lfh7PJdseyxCC3rTBe40ksYvYpLvapDicV6ZsD3viJqDHhWVzqXh7b3DBmoYkr63BcDRutsakQkenB2NFw4_tZmh3H62oWzLEJwkhgFluw9Pfp46fHbvGx93fSI1hsdh9aceuufb8PS7Z7vas8a0BtNBzrA5iX76N-PjwspPkD1Ub0FA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50FdGD78f6jOLBS8U2rxa8iLoorov4Ym8lTVJYkK5sd_39Jk22KioI3gqZkpDJJDOZyfcBHCqsCWOaBma5kMDEX2EQM5oExpkw3i7B0qULntu804m73eRuAk7Hb2EcPkR94WYto9qvrYHrV5V_svJyMDy2ERabhCliSWQaMHVx33pqf5R4JI4eOTlJAk6jrkcWspU89c9fz6NvTuZXn7U6dFoL_xvuIsx7ZxOdudWxBBO6WIa5TxCEyzBz65PrK3Bl4ZxE9QgJiUIhW3WOPB8P6udIyEKjUppIGPUK5AFZS2Rvcl3b28i-C-mVq_DUunw8vwo80UIgcRyzgGDOcaa0sUeuBOc6NMc2pyqLchayHGvBEx5mOBGMhiIjLFIkp5EUNGMKiwivQaPoF3oDkCTS7IE0y2WsCLWMNjyXgkda0lCeZGETjsbTnUqPQm7JMF7ScTRi5imt5qkJB7Xoq4Pe-Eloe6yz1FtfmdrsMGaxiSybsF83G7uxyRBR6P7IyXDj_VmZdafruhfMsQnDSGQGW6n09-7Th_vH6mPz76J7MHN30Urb152bLZi19PWu9GwbGsPBSO_AtHwb9srBrl_O7-vd9So |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+risk+factors+of+acne+scars+in+patients+with+acne+vulgaris&rft.jtitle=Skin+research+and+technology&rft.au=Liu%2C+Lin&rft.au=Xue%2C+Yuzhou&rft.au=Chen%2C+Yangmei&rft.au=Chen%2C+Tingqiao&rft.date=2023-06-01&rft.issn=1600-0846&rft.eissn=1600-0846&rft.volume=29&rft.issue=6&rft.spage=e13386&rft_id=info:doi/10.1111%2Fsrt.13386&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0909-752X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0909-752X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0909-752X&client=summon |